Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,472.00
Bid: 12,492.00
Ask: 12,496.00
Change: 74.00 (0.60%)
Spread: 4.00 (0.032%)
Open: 12,432.00
High: 12,526.00
Low: 12,318.00
Prev. Close: 12,398.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK PM: Covid passports may not be possible until full vaccine rollout

Thu, 25th Mar 2021 15:03

(Alliance News) - UK Prime Minister Boris Johnson has said it may not be feasible to implement coronavirus health certificates until everyone has been offered a vaccine, as publicans criticised his plans.

The prime minister said on Thursday that the government will say more on their possible use in early April, and suggested they could also be based on whether individuals have developed antibodies through infection, as well as vaccinations and negative tests.

But landlords rejected their use after his earlier suggestion it could be up to them to decide whether to screen customers' certificates on entry, ahead of fresh details emerging of a possible incentive for pubs to adopt the measure.

Johnson also defended his credentials as a "freedom lover" as some lockdown-sceptic Conservative backbenchers prepared to rebel in a Commons vote to extend coronavirus laws for a further six months.

The boss of the Shepherd Neame chain said that making jabs mandatory for entry to pubs is a "fairly poorly thought-out idea", as trade bodies suggested the idea was "simply unworkable".

Johnson insisted "no decisions have been taken at all", saying that there will be an update on the review into their possible use on either April 5 or 12, and said that "whatever happens" the April 12 reopening of pub gardens will be unaffected.

The prime minister said that "I do think there is going to be a role for certification", though it is possible this will be limited to foreign travel.

"There are three basic components. There's the vaccine, there's your immunity you might have had after you've had Covid and there's testing – they are three things that could work together," Johnson told broadcasters during a visit to the Monkey Puzzle Day Nursery in Greenford.

But he acknowledged there are "moral complexities" and "ethical problems" that must be addressed, raising concerns that pregnant women and those with medical reasons cannot be vaccinated.

"You might only be able to implement a thoroughgoing vaccination passport scheme, even if you wanted such a thing, in the context of when absolutely everybody had been offered a vaccine," Johnson added.

Ministers have insisted that their target of offering all adults a vaccine by the end of July will be met despite the EU's threat to control supplies from the continent.

EU leaders will discuss proposals aimed at tightening restrictions on vaccine exports at a virtual European Council summit on Thursday.

Meanwhile, MPs will be asked to approve the regulations for the route out of lockdown and keep some of the emergency powers in the Coronavirus Act in place until September.

Though they are expected to pass comfortably because Labour will not oppose them, the leader of the Covid Recovery Group of lockdown-sceptic Tory MPs was highly critical of the move.

Mark Harper, a former chief whip, said he has not "heard a single good answer about why" the government wants to extend "very significant draconian powers" for a further six months.

Ahead of the vote, Johnson said: "The libertarian in me is also trying to protect people's fundamental right to life and their ability to live their lives normally.

"And the only way really to restore that for everybody is for us to beat the disease and the best path to freedom is down the cautious but irreversible road map that we've set out – that's what the freedom lover wants."

On Wednesday, the prime minister said it "may be up to individual publicans" whether they carry out health certificate checks on punters.

Jonathan Neame, the chief executive of Shepherd Neame pub group, ruled out making vaccines mandatory for entry to his premises, warning bar staff could be "subject to intimidation".

"This is fraught with difficulty, I think, and it is, in my view, a fairly poorly thought out idea at this stage," he told BBC Radio 4's Today programme.

Kate Nicholls, the chief executive of the UKHospitality trade body, said the plan is "simply unworkable" and the British Beer and Pub Association said the requirement would not be "appropriate or necessary".

Cabinet Office minister Michael Gove is reviewing the possible use of coronavirus status certificates under plans to ease England's lockdown.

The use of certificates may not be as straightforward as vaccine or no vaccine, as recent negative test status may also be considered.

A Whitehall source told the PA news agency that landlords may be able to scrap social distancing if they check Covid health certificates on entry, in a move that would allow them to operate at much higher capacity.

Under the suggestion being considered in the review, those who do not want to enforce the checks would be allowed to reopen but would have to ensure social distancing is maintained.

Johnson insisted "blockades" are not the way forward as EU leaders were holding a virtual meeting to discuss tightening vaccine export restrictions, as the bloc is embroiled in an enduring row over supply with AstraZeneca PLC.

A joint statement moving to cool tensions said the two sides were seeking a "win-win" deal to increase supplies across the UK and EU.

Government data up to Tuesday showed 28.7 million people have received a first vaccine dose, a rise of 325,650 on the previous day.

A further 98 people had died within 28 days of testing positive for Covid-19 as of Wednesday, bringing the total by that measure to 126,382.

As of 9am on Wednesday, there had been a further 5,605 lab-confirmed cases in the UK, bringing the total to 4.3 million.

By Sam Blewett

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
2 Apr 2024 09:54

LONDON BROKER RATINGS: Bernstein starts AstraZeneca at 'outperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
2 Apr 2024 09:09

LONDON MARKET OPEN: FTSE 100 up as oil majors and gold miners shine

(Alliance News) - Stock prices in London opened higher on Tuesday, in confident trade following the long Easter weekend, ahead of a UK manufacturing sector reading later in the morning.

Read more
2 Apr 2024 08:05

LONDON BRIEFING: HSBC in special payout on Canada sale; Astra FDA win

(Alliance News) - London's FTSE 100 traded higher on Tuesday following the long weekend, as investors react to US data, and look ahead to manufacturing sector readings from Europe later.

Read more
2 Apr 2024 07:08

US FDA gives green light for use of AstraZeneca's Voydeva

(Sharecast News) - America's drug regulator gave the green light to AstraZeneca's for the add-on use of Voydeya in the treatment of extravascular haemolysis (EVH) in patients with paroxysmal nocturnal haemoglobinuria (PNH).

Read more
27 Mar 2024 12:02

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the release of the US Federal Reserve's preferred inflation gauge on Friday.

Read more
27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation.

Read more
27 Mar 2024 09:19

AstraZeneca treatments become "first and only" to be approved in Japan

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan.

Read more
27 Mar 2024 09:03

LONDON MARKET OPEN: FTSE 100 slips as unease lingers before US data

(Alliance News) - Stock prices in London edged lower after the open on Wednesday, with some nervy trade ahead of a US inflation reading later in the week.

Read more
27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation reading later in the week.

Read more
26 Mar 2024 10:18

China to speed up 'new productive forces', vice president says

BEIJING, March 26 (Reuters) - China will accelerate the development of "new productive forces" and bolster stability and security for the global economy, Vice President Han Zheng told an investment forum in Beijing, as the world's no.2 economy seeks to reassure anxious foreign firms.

Read more
25 Mar 2024 12:09

LONDON MARKET MIDDAY: Stocks make tepid start to new week

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.

Read more
25 Mar 2024 09:04

LONDON MARKET OPEN: FTSE 100 treads water, FTSE 250 declines

(Alliance News) - The FTSE 100 in London traded flat early Monday, while the pound remained below the USD1.26 mark, as Bank of England Governor Andrew Bailey suggested rate cuts may happen soon.

Read more
25 Mar 2024 08:40

TOP NEWS: AstraZeneca wins US approval for rare nervous system disease

(Alliance News) - AstraZeneca PLC on Monday said its Ultomiris treatment has been approved by the US Food & Drug Administration as the first and only long-acting C5 complement inhibitor to treat neuromyelitis optica spectrum disorder in adults.

Read more
25 Mar 2024 07:59

LONDON BRIEFING: AstraZeneca wins US approval, Kingfisher profit down

(Alliance News) - London's FTSE 100 is set to open lower on Monday, giving back some of last week's progress, when equities were boosted by hope of interest rate cuts.

Read more
25 Mar 2024 07:23

AstraZeneca gets FDA approval for Ultomiris treatment

(Sharecast News) - AstraZeneca has announced that its autoimmune disease treatment Ultomiris has been given the green light by US regulators.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.